CCEL — Cryo-Cell International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Cryo-Cell International, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2019 November 30th	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7.45	10.4	8.34	1.72	0.98
Net Total Accounts Receivable
Net Total Receivables	6.1	6.32	5.25	6.04	6.58
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.4	18.6	15.8	9.61	9.45
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.85	1.94	4.15	14.2	22
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	42.9	46.2	60.7	64.9	61.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.4	16.4	21.1	19.5	20.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	49.8	48.9	56.5	66.4	72.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-6.95	-2.67	4.18	-1.52	-11
Total Liabilities & Shareholders' Equity	42.9	46.2	60.7	64.9	61.2
Total Common Shares Outstanding